Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Pridopidine for the Treatment of ALS–Improvements in the Subgroup of Definite, Probable, and Early (<18mo from Onset) Subjects in the Phase 2 Healey ALS Platform Trial

              Author:Geva, Michal   Shefner, Jeremy   Oskarsson, Bjorn   Lichtenstein, Rachel G.   Meltzer, May   Cohen, Yael   Hand, Randal   Chen, Kelly   Leitner, Melanie   Paganoni, Sabrina   Cudkowicz, Merit   Hayden, Michael   

              Session Name:S5: Updates on Amyotrophic Lateral Sclerosis  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:S5.010  

              Author Institution:Prilenia Therapeutics, Herzlyia, Israel  Barrow Neurological Institute, Phoenix, AZ  Mayo Clinic, Jacksonville, FL  Prilenia Therapeutics, Kibbutz Yakum, Israel  Accelerating NeuroVentures, LLC, Needham, MA  Massachusetts General Hospital, Boston, MA  Prilenia Therapeutics and University of British Columbia, Herzliya, Israel  

              The Phase 3 PROOF-HD Trial Demonstrates Meaningful Benefits of Pridopidine on Function, Cognition, and Motor Signs in Huntington Disease (HD)

              Author:Geva, Michal   Reilmann, Ralf   Feigin, Andrew   Rosser, Anne   Kostyk, Sandra   Chen, Kelly   Hand, Randal   Boot, Diderik   Cohen, Yael   Goldberg, Paul   Hayden, Michael   

              Session Name:PL5: Clinical Trials Plenary Session  

              Topic:Movement Disorders  

              Program Number:PL5.002  

              Author Institution:Prilenia Therapeutics, Herzlyia, Israel  George-Huntington-Institute, Muenster, Germany  NYU Langone Health, New York, NY  Ohio State University College of Medicine, Dublin, OH  Prilenia Therapeutics, Kibbutz Yakum, Israel  Prilenia Therapeutics and University of British Columbia, Herzliya, Israel  

              The Effect of Antidopaminergic Medications on Changes in Clinical Measures of Huntington’s Disease Function, Cognition, Motor Signs, and Progression

              Author:Hand, Randal   Geva, Michal   Goldberg, Paul   Chen, Kelly   Long, Jeffrey   Hayden, Michael   

              Session Name:P10: Movement Disorders: Hyperkinetic Movement Disorders: Dystonia, Chorea, Tics, Myoclonus, and RLS  

              Topic:Movement Disorders  

              Program Number:P10.030  

              Author Institution:Prilenia Therapeutics, Kibbutz Yakum, Israel  Prilenia Therapeutics and University of British Columbia, Kibbutz Yakum, Israel